ARCHIVES

Breast Cancer: Pitt “Regrets” Any Harm, Expresses Pride In Fisher’s Work

This article is from The Cancer Letter archive.

Vol. 23 No. 34 | September 5, 1997

Download PDF Visit The Full Archive

Related Articles

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Cancer Policy Board urges distinct care for cancer survivors.

November 11, 2005

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

June 26, 2009

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011